The bill establishes the Minnesota Parkinson's Research Trust Fund, aimed at supporting innovative research on Parkinson's disease and providing assistance to caregivers. It includes provisions for the creation of a special revenue fund that is separate from the general fund, with the purpose of advancing research, improving patient outcomes, and alleviating the financial burden associated with Parkinson's disease. The fund will facilitate grants to various institutions involved in Parkinson's research and will be overseen by a newly formed Neurodegenerative Disease Advisory Council, which will include representatives from research institutions, advocacy organizations, caregiver support groups, and the medical community.

Additionally, the bill appropriates $25 million from the general fund for fiscal year 2027 to implement the trust fund's objectives. This allocation includes $20 million for competitive grants to research institutions focused on innovative therapies, $3 million for caregiver support programs, and $2 million for the establishment of the advisory council. The bill also mandates annual reporting requirements for grant recipients and the commissioner of health, ensuring transparency and accountability in the use of funds. The effective date for the trust fund is set for October 1, 2026, while the appropriation section will take effect on July 1, 2026.